| LUNG Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LUNG market cap history going back to 10/1/2020:
Also see: LUNG Shares Outstanding History and LUNG YTD Return |
As of 4/27/2026 Pulmonx has a market cap of 54.06 million. Investors often follow the LUNG market cap history to compare the size of the company over time.
This page shows LUNG market capitalization trends over time, with 24 market cap datapoints presented, dating back to 10/1/2020.

| LUNG Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the LUNG market cap history going back to 10/1/2020:
Also see: LUNG Shares Outstanding History and LUNG YTD Return |
| LUNG Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
LUNG Historical Market Cap: -42.73% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| LUNG Stock Price Chart |
| About Pulmonx Corp |
| Pulmonx Corporation is a commercial-stage medical technology company. Co. provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. We show 24 historical shares outstanding datapoints in our LUNG shares outstanding history coverage, used to compute LUNG market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LUNG market cap history over the course of time is important for investors interested in comparing LUNG's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LUNG versus a peer is one thing; comparing LUNG market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LUNG can fluctuate over the course of history. With this page we aim to empower investors researching LUNG by allowing them to research the LUNG market cap history. |
| LUNG Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| LUNG Share Performance |
| Market Cap Peers |
| Pulmonx (LUNG) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
LVGO Market Cap History LXEO Market Cap History LXRX Market Cap History LYEL Market Cap History LYRA Market Cap History MACK Market Cap History MASI Market Cap History MBIO Market Cap History MBOT Market Cap History MBRX Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.